All articles tagged with #superbug
Nevada experienced a 33% increase in cases of the drug-resistant fungus C. auris, with the CDC underreporting the total cases, which now exceed 7,200 since 2021, highlighting ongoing infection control challenges in healthcare settings.
Experts warn about Candida auris, a multi-drug resistant fungus detected in Connecticut, which poses a significant threat in healthcare settings due to its resistance to treatment, ability to spread rapidly, and difficulty in detection, primarily affecting immunocompromised patients in hospitals and nursing homes.
A deadly, drug-resistant fungus called Candida auris is spreading globally, particularly in U.S. hospitals, posing a significant health threat due to its resistance to multiple antifungal drugs and ability to spread on surfaces and equipment. Researchers warn that current diagnostics and treatments lag behind the fungus's evolution, emphasizing the urgent need for new antifungal agents, improved detection, and increased awareness, especially in resource-poor countries. Despite challenges, recent studies suggest potential vulnerabilities in the fungus that could lead to new treatment strategies.
A deadly, drug-resistant fungus called Candida auris is spreading globally, particularly in U.S. hospitals, posing a significant health threat due to its resistance to multiple antifungal drugs and difficulty in detection. Researchers emphasize the urgent need for new treatments, improved diagnostics, and better infection control measures to combat this emerging superbug.
A drug-resistant fungus called Candida auris is rapidly spreading across U.S. hospitals and globally, posing a serious health threat due to its resistance to multiple antifungal drugs and ability to survive on surfaces and skin. Experts warn that current diagnostics and treatments are insufficient, emphasizing the need for new antifungal agents, better surveillance, and awareness to combat this emerging superbug.
A deadly, drug-resistant fungus called Candida auris has infected at least 7,000 people across 27 U.S. states in 2025, spreading rapidly in healthcare settings and potentially worsened by climate change, with no effective treatments for resistant strains, posing a significant public health threat.
A deadly, drug-resistant fungus called Candida auris has infected at least 7,000 people across 27 U.S. states in 2025, spreading rapidly in healthcare settings and posing a significant public health threat due to its resistance to treatment and possible links to climate change.
The CDC reports a dramatic 460% increase in infections caused by the drug-resistant bacteria NDM-CRE in the U.S., raising concerns about treatment challenges and the need for cautious antibiotic use and hygiene practices, especially among vulnerable populations.
Scientists warn of rising MRSA infections in community settings like gyms, with younger people increasingly affected. The US CDC and UK health authorities advise improved hygiene practices, such as not sharing towels or razors and covering cuts, to prevent spread. Although rates are still low compared to past decades, the trend of community-acquired MRSA is being closely monitored, raising concerns about potential shifts in infection patterns.
A new antibiotic called zosurabalpin, developed by Roche, is entering late-stage human trials and could be the first new class of antibiotics in 50 years to combat the deadly drug-resistant bacteria Acinetobacter baumannii, offering hope in the fight against superbugs and antibiotic resistance.
Roche is advancing its experimental antibiotic zosurabalpin into Phase 3 clinical trials to combat drug-resistant acinetobacter baumannii, a bacteria causing serious hospital infections, using a novel mode of action to which bacteria have not yet developed resistance.
Roche is advancing a new antibiotic, zosurabalpin, into late-stage clinical trials to combat resistant Gram-negative bacteria like acinetobacter, which cause severe infections and have become difficult to treat, marking a potential breakthrough after over 50 years.
A 29-year-old woman in Australia died after being attacked by a superbug that led to septic shock and pneumonia, ultimately causing her organs to fail. Ashley Timbery collapsed at home and was diagnosed with a Methicillin-resistant Staphylococcus aureus (MRSA) infection, which doctors believe led to her death. Despite showing only mild symptoms initially, her condition rapidly deteriorated, and she passed away after doctors informed her family that she wouldn't recover.
A 29-year-old woman from Nowra, Australia, died suddenly after contracting a superbug that attacked her organs, leading to pneumonia and sepsis. The bug, identified as Methicillin-resistant Staphylococcus aureus (MRSA), caused her lungs to be covered in holes. The family is devastated by the loss and is raising funds for her unexpected funeral costs. MRSA is a type of staph bacteria resistant to antibiotics and can cause severe infections if left untreated.
Southern Nevada hospitals and nursing homes reported a record high of 69 invasive infections and 133 colonization cases of the drug-resistant "superbug" fungus Candida auris in January, with the majority of cases detected in the region. The fungus, which can be deadly and is difficult to treat, spreads in healthcare facilities and has been mutating in ways that make existing drugs less effective. Health officials attribute the peak in cases to reporting lags and the adoption of a new state regulation requiring facilities to report cases. Sunrise Hospital and Medical Center has reported the highest number of cases in the state and actively screens at-risk patients for the fungus.